STRECK PAUL 4
4 · PepGen Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
PepGen (PEPG) EVP Paul Streck Sells Shares
What Happened
Paul Streck, EVP and Head of R&D at PepGen (PEPG), had 1,879 shares sold on his behalf on March 4, 2026. The sales consisted of 1,832 shares at $6.23 ($11,413) and 47 shares at $6.29 ($296), for a total of roughly $11,709. These were sales (not purchases) and reflect a routine tax-withholding action tied to RSU vesting, not an exercise of bullish conviction.
Key Details
- Transaction dates & prices: 2026-03-04 — 1,832 sh @ $6.23; 47 sh @ $6.29.
- Total shares sold: 1,879; total proceeds ≈ $11,709.
- Shares owned after transaction: Not reported in the provided filing excerpt.
- Footnote: Sales were automatic sell-to-cover transactions executed by the company to satisfy minimum statutory tax withholding on vested RSUs. The RSU agreement provided for the mandatory sale and the filing notes this was not a discretionary trade (consistent with a binding contract / 10b5-1 affirmative defense).
- Filing: Report filed 2026-03-06 for transactions on 2026-03-04; appears to be timely (Form 4s are generally due within two business days).
Context
This was a tax-withholding sale tied to RSU vesting — a common, routine event that does not necessarily indicate the insider's view on the company's outlook. Retail investors often weigh purchases more heavily than routine sell-to-cover transactions when assessing insider sentiment.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-04$6.23/sh−1,832$11,413→ 76,273 total - Sale
Common Stock
[F1]2026-03-04$6.29/sh−47$296→ 76,226 total
Footnotes (1)
- [F1]Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units ("RSUs"). The mandatory sale of the Reporting Person's shares was provided for in a RSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.